Shared on07 Aug 25Fair value Decreased 4.50%
Despite ongoing pricing normalization, mixed end-market trends, and management's cautiously optimistic FY25 outlook, analysts expect earnings to stabilize and financial performance to improve, resulting in an unchanged consensus price target of $66.60. Analyst Commentary Increased likelihood of earnings stabilization.
Shared on23 Apr 25Fair value Increased 0.22%
AnalystConsensusTarget has increased revenue growth from -1.7% to -1.6%.
Shared on17 Apr 25Fair value Decreased 2.68%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 3.28%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Increased 1.67%
AnalystConsensusTarget has decreased revenue growth from 0.5% to -1.6%, decreased profit margin from 6.1% to 3.9%, increased future PE multiple from 18.9x to 25.4x and increased discount rate from 7.9% to 8.8%.